Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/26085| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Brezovska, Marija | en_US |
| dc.contributor.author | Acevska, Jelena | en_US |
| dc.contributor.author | Nakov, Natalija | en_US |
| dc.contributor.author | Ugrinova, Liljana | en_US |
| dc.contributor.author | Tonic Ribarska, Jasmina | en_US |
| dc.date.accessioned | 2023-03-13T11:33:46Z | - |
| dc.date.available | 2023-03-13T11:33:46Z | - |
| dc.date.issued | 2022-12-31 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/26085 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Macedonian Pharmaceutical Association | en_US |
| dc.relation.ispartof | Macedonian Pharmaceutical Bulletin | en_US |
| dc.title | Comparative analysis of the regulatory framework for postmarketing authorization changes in EU and USA | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.33320/maced.pharm.bull.2022.68.03.098 | - |
| dc.identifier.url | https://bulletin.mfd.org.mk/volumes/Volume%2068_3/68_3_098.pdf | - |
| dc.identifier.volume | 68 | - |
| dc.identifier.issue | 03 | - |
| dc.identifier.fpage | 205 | - |
| dc.identifier.lpage | 206 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Pharmacy | - |
| crisitem.author.dept | Faculty of Pharmacy | - |
| Appears in Collections: | Faculty of Pharmacy: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.